ArticleLancet regional health. Americas2026

Health care utilization and cost implications of Chile's 2024 nirsevimab strategy for RSV prevention: a counterfactual analysis.

Denis Sauré et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.